141 related articles for article (PubMed ID: 19942713)
1. Knockdown of ICB-1 gene enhanced estrogen responsiveness of ovarian and breast cancer cells.
Konwisorz A; Springwald A; Haselberger M; Goerse R; Ortmann O; Treeck O
Endocr Relat Cancer; 2010 Mar; 17(1):147-57. PubMed ID: 19942713
[TBL] [Abstract][Full Text] [Related]
2. Expression of differentiation-associated gene icb-1 is estrogen-responsive in ovarian and breast cancer cell lines.
Bollmann J; Ortmann O; Treeck O
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):16-21. PubMed ID: 18206364
[TBL] [Abstract][Full Text] [Related]
3. Expression of icb-1 gene is interferon-gamma inducible in breast and ovarian cancer cell lines and affects the IFN gamma-response of SK-OV-3 ovarian cancer cells.
Treeck O; Kindzorra I; Pauser K; Treeck L; Ortmann O
Cytokine; 2005 Nov; 32(3-4):137-42. PubMed ID: 16219472
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Treeck O; Lattrich C; Springwald A; Ortmann O
Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
[TBL] [Abstract][Full Text] [Related]
5. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
Mishra AK; Abrahamsson A; Dabrosin C
Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755
[TBL] [Abstract][Full Text] [Related]
6. Icb-1 expression inhibits growth and fulvestrant response of breast cancer cells and affects survival of breast cancer patients.
Riedmeier M; Skrzypczak M; Schüler-Toprak S; Ortmann O; Treeck O
Arch Gynecol Obstet; 2021 Jul; 304(1):203-213. PubMed ID: 33389102
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.
Imai Y; Ishikawa E; Asada S; Sugimoto Y
Cancer Res; 2005 Jan; 65(2):596-604. PubMed ID: 15695404
[TBL] [Abstract][Full Text] [Related]
8. Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens.
Andersen CL; Sikora MJ; Boisen MM; Ma T; Christie A; Tseng G; Park Y; Luthra S; Chandran U; Haluska P; Mantia-Smaldone GM; Odunsi K; McLean K; Lee AV; Elishaev E; Edwards RP; Oesterreich S
Clin Cancer Res; 2017 Jul; 23(14):3802-3812. PubMed ID: 28073843
[No Abstract] [Full Text] [Related]
9. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
[TBL] [Abstract][Full Text] [Related]
10. Differential induction of LRP16 by liganded and unliganded estrogen receptor alpha in SKOV3 ovarian carcinoma cells.
Tian L; Wu Z; Zhao Y; Meng Y; Si Y; Fu X; Mu Y; Han W
J Endocrinol; 2009 Jul; 202(1):167-77. PubMed ID: 19403568
[TBL] [Abstract][Full Text] [Related]
11. Silencing of the icb-1 gene inhibits the induction of differentiation-associated genes by vitamin D3 and all-trans retinoic acid in gynecological cancer cells.
Haselberger M; Springwald A; Konwisorz A; Lattrich C; Goerse R; Ortmann O; Treeck O
Int J Mol Med; 2011 Jul; 28(1):121-7. PubMed ID: 21455565
[TBL] [Abstract][Full Text] [Related]
12. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
13. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer.
Thewes V; Simon R; Schroeter P; Schlotter M; Anzeneder T; Büttner R; Benes V; Sauter G; Burwinkel B; Nicholson RI; Sinn HP; Schneeweiss A; Deuschle U; Zapatka M; Heck S; Lichter P
Cancer Res; 2015 Feb; 75(4):720-31. PubMed ID: 25643697
[TBL] [Abstract][Full Text] [Related]
15. icb-1 Gene counteracts growth of ovarian cancer cell lines.
Treeck O; Schüler S; Häring J; Skrzypczak M; Lattrich C; Ortmann O
Cancer Lett; 2013 Jul; 335(2):441-6. PubMed ID: 23474491
[TBL] [Abstract][Full Text] [Related]
16. Silencing MED1 sensitizes breast cancer cells to pure anti-estrogen fulvestrant in vitro and in vivo.
Zhang L; Cui J; Leonard M; Nephew K; Li Y; Zhang X
PLoS One; 2013; 8(7):e70641. PubMed ID: 23936234
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
18. A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells.
Wang B; Li D; Rodriguez-Juarez R; Farfus A; Storozynsky Q; Malach M; Carpenter E; Filkowski J; Lykkesfeldt AE; Kovalchuk O
BMC Cancer; 2018 Aug; 18(1):817. PubMed ID: 30103729
[TBL] [Abstract][Full Text] [Related]
19. Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
Osipo C; Meeke K; Cheng D; Weichel A; Bertucci A; Liu H; Jordan VC
Int J Oncol; 2007 Feb; 30(2):509-20. PubMed ID: 17203234
[TBL] [Abstract][Full Text] [Related]
20. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
